Olisaemeka Ogbue, MD

350 posts

Olisaemeka Ogbue, MD banner
Olisaemeka Ogbue, MD

Olisaemeka Ogbue, MD

@olisaogbue

Heme/Onc fellow @Mayoclinic via @clevelandclinic Fairview Internal Medicine🇳🇬🇺🇸 Translational research/Leukemia/Clonal hematopoiesis

Katılım Kasım 2010
727 Takip Edilen679 Takipçiler
Olisaemeka Ogbue, MD
Olisaemeka Ogbue, MD@olisaogbue·
I’m deeply honored to receive the 2026 #EAOnc Paul Carbone, MD Fellowship Award. Thankful to my mentors at Mayo Clinic for their guidance, encouragement, and investment in my development @MrinalPatnaik @AlkaliDr @AntoineNSaliba @tariqkewan @MayoCancerCare @MayoHemeOnc @eaonc
ECOG-ACRIN Cancer Research Group@eaonc

Congratulations to @olisaogbue of @MayoClinic on receiving the 2026 #EAOnc Paul Carbone, MD Fellowship Award! #PredictiveModeling #LateEffects #CancerSurvivorship #AYACancer

English
3
3
18
1.5K
Onyedikachi Adike. MD, MPH
Onyedikachi Adike. MD, MPH@JudeAdike·
It began like a dream, But today, it’s a reality. I am thrilled to announce that I matched into the UPMC Diagnostic Radiology Residency @PittRadiology Special thanks to my mentors and friends who supported and guided me through this process. I’m super grateful. #Match2026
Onyedikachi Adike. MD, MPH tweet mediaOnyedikachi Adike. MD, MPH tweet media
English
150
234
2.2K
64.1K
Olisaemeka Ogbue, MD
Olisaemeka Ogbue, MD@olisaogbue·
Grateful to co-authors and mentors for this collaborative effort.
English
0
0
1
103
Olisaemeka Ogbue, MD
Olisaemeka Ogbue, MD@olisaogbue·
What this means clinically: 🔹 CH may help guide surveillance as PARP inhibitors and radioligand therapies move earlier in treatment. It also offers a window into therapy tolerance and long-term hematologic risk in mCRPC.
English
1
0
1
108
Aiman J. Faruqi, MD, MS
Beyond thrilled to have matched at @MDAndersonNews for heme/onc fellowship, a dream come true many years in the making. I could not be more grateful to my family, mentors, and the phenomenal training I received at @MayoMN_IMRES that made it possible.
Aiman J. Faruqi, MD, MS tweet media
English
9
2
81
5.7K
Chibuzor Ogamba
Chibuzor Ogamba@uzor_md·
Delighted to share our latest research published with @SpringerNature in @SciReports. We show that financial toxicity is a key driver of health-related quality of life among gynecological cancer patients in Nigeria - and identify associated factors. rdcu.be/eyLAl
Chibuzor Ogamba tweet mediaChibuzor Ogamba tweet mediaChibuzor Ogamba tweet media
English
3
7
22
2K
Olisaemeka Ogbue, MD retweetledi
Caner Saygin, MD
Caner Saygin, MD@CanerSaygin·
Very excited to share our paper investigating the evolution of therapy-related CH in myeloma pts treated w/ or w/o LEN. Can we predict the risk for second blood cancer in myeloma pts? Grateful for the collaboration with @UCCancerCenter myeloma program. nature.com/articles/s4137…
English
8
24
85
8.5K
Islam B. Mohamed MD, MSc
Islam B. Mohamed MD, MSc@drislambadr·
🚨 Just Submitted my #GIFellowship application! 💩 From Egypt to Houston to Cleveland, thankful for the journey. Grateful for my mentors. You’re my heros. Dedicated to advancing equitable care for liver patients. 📌AAMC ID: 13695481 🩺 Excited for what’s ahead! 💡 #ERAS2025
Islam B. Mohamed MD, MSc tweet media
English
26
8
146
10.4K
Prabhat Kumar, MD
Prabhat Kumar, MD@PrabhatKumarMD·
🎯 Pleased to share our latest Hepatology Highlights article published in @HEP_Journal : 📝"Two heads are better than one: The synergy of carvedilol and simvastatin" 🧠 This piece discusses the potential complementary role of dual pharmacotherapy in managing portal hypertension. 📉💊 Grateful to the legendary @juanpabloarab for the opportunity and guidance throughout this collaboration!🙏 📖 Read here: pubmed.ncbi.nlm.nih.gov/40536391/ #VCU #Hepatology #MedTwitter @AASLDtweets #GITwitter @AmerGastroAssn @AmCollegeGastro @VCU_Liver
Prabhat Kumar, MD tweet media
English
2
6
47
2.2K